Tenet Healthcare THC
$263.19 −$0.40 (-0.15%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $263.19 0.00%
Open$265.14
Prev close$263.59
Day range$261.15 – $266.62
Volume705.0K
Market cap$20.95B
P/E (TTM)7.7
Dividend yield–
Analyst view
ConsensusBuy
Analysts16
Average target$308.27+17.1% vs. price
- Buy 88%
- Hold 13%
Low $265.00Now $263.19Avg $308.27High $342.00
Recent rating changes
The last 20 actions on file set price targets from $274.00 to $342.00, averaging $307.79.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 15 Nov 2026 | Mizuho Securities | BUY | $330.00 |
| 11 Nov 2026 | Mizuho Securities | BUY | $330.00 |
| 10 Nov 2026 | Goldman Sachs | BUY | $320.00 |
| 5 Nov 2026 | BofA Securities | BUY | – |
| 4 Nov 2026 | Barclays | BUY | $297.00 |
| 3 Nov 2026 | KeyBanc | BUY | $300.00 |
| 2 Nov 2026 | TD Cowen | BUY | $302.00 |
| 2 Nov 2026 | Wells Fargo | BUY | $321.00 |
| 2 Nov 2026 | UBS | BUY | $340.00 |
| 2 Nov 2026 | Mizuho Securities | BUY | $305.00 |
| 2 Nov 2026 | Leerink Partners | BUY | $342.00 |
| 1 Nov 2026 | RBC Capital | BUY | $304.00 |
| 30 Oct 2026 | Raymond James | BUY | $300.00 |
| 30 Oct 2026 | Baird | HOLD | $285.00 |
| 30 Oct 2026 | Morgan Stanley | BUY | $297.00 |
| 29 Oct 2026 | BofA Securities | BUY | $305.00 |
| 29 Oct 2026 | Guggenheim | BUY | $306.00 |
| 16 Oct 2026 | Guggenheim | BUY | $307.00 |
| 12 Oct 2026 | Morgan Stanley | BUY | $274.00 |
| 7 Oct 2026 | RBC Capital | BUY | $283.00 |
No comments yet — be the first to weigh in on THC.
Sign in to join the discussion.